Article
Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants.
The Journal of pharmacology and experimental therapeutics - 1 Dec 2007
Lamba Jatinder K, Crews Kristine, Pounds Stanley, Schuetz Erin G, Gresham Jessica, Gandhi Varsha, Plunkett William, Rubnitz Jeffrey, Ribeiro Raul
Abstract excerpt
Deoxycytidine kinase (DCK) is a rate-limiting enzyme in the activation of nucleoside analogs such as cytarabine (ara-C), gemcitabine, clofarabine, and others. The present study was undertaken to identify and to determine the functional consequences of genetic variants in DCK. We sequenced 1.5 kil...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
